We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Michael L. Casner
Michael L. Casner
Products
PRODUCTS
Frontida BioPharm, Inc.
Michael L. Casner
and
Jaison J. Eapen
Price:
$117.00
View
Chunghwa Chemical Synthesis & Biotech Co. Ltd.
Michael L. Casner
Price:
$117.00
View
K. Patel Phyto Extractions Pvt. Ltd.
Michael L. Casner
Price:
$117.00
View
Laboratorios Leon Farma SA
Michael L. Casner
,
James Norman
, and
Seema S. Singh
Price:
$117.00
View
Polysciences, Inc.
Michael L. Casner
,
Marcelo O. Mangalindan
, and
Deborah J. Parris
Price:
$117.00
View
BioSpectra, Inc.
Michael L. Casner
,
James M. Mason
, and
Deborah J. Parris
Price:
$117.00
View
Upcoming Events
12
May
Extractables and Leachables: 101
19
May
CDRH’s New Accreditation Scheme for Conformity Assessment: Impacts on Your Future Testing Plans and FDA Submissions
25
May
How Can the Accelerated Availability of Pfizer-BioNTech’s COVID-19 Vaccine be Replicated?
26
May
Biopharmaceutical Supply Chain Issues Before, During and After the Pandemic: Impact on the Pharmaceutical Industry’s Regulatory, Quality and Compliance Professionals
27
May
Evolving Clinical Trials: Continuing the Journey from Paper to Digital
09
Jun
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
AstraZeneca’s Imfinzi and Tremelimumab Helped NSCLC Patients Live Longer
Perosphere Technologies Obtains CE Mark for Blood Coagulation Meter
Inovio’s COVID-19 Vaccine Poised for Phase 3 Trial, but FDA Partial Hold Remains
Olympus Receives FDA Clearance for Airway Mobilescopes
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
